2 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Umoja Competitors or Alternatives

Umoja's top competitors include Tmunity, PACT Pharma and Geneos Therapeutics.

Unlock 15 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Umoja's company profile

Andrew M. Scharenberg

Co-Founder & CEO

90/100
25 - 100
$363M
$100K - 5M
  • $363M
    $100K - 5M
  • 25 - 100
    $363M
  • $100K - 5M
  • 90/100
  • 25 - 100
  • $363M
  • $100K - 5M
View ProfileView
1
Umoja's Competitor - Tmunity logo

Sujay Kango

President & CEO

82/100
25 - 100
$230M
$5M - 25M
  • $230M
    $5M - 25M
  • 25 - 100
    $230M
  • $5M - 25M
  • 82/100
  • 25 - 100
  • $230M
  • $5M - 25M
View ProfileView
2
Umoja's Competitor - PACT Pharma logo

Scott Garland

CEO

86/100
25 - 100
$200.5M
$5M - 25M
  • $200.5M
    $5M - 25M
  • 25 - 100
    $200.5M
  • $5M - 25M
  • 86/100
  • 25 - 100
  • $200.5M
  • $5M - 25M
View ProfileView
3
Umoja's Competitor - Geneos Therapeutics logo

Niranjan Y. Sardesai

President & CEO

84/100
25 - 100
$60M
$100K - 5M
  • $60M
    $100K - 5M
  • 25 - 100
    $60M
  • $100K - 5M
  • 84/100
  • 25 - 100
  • $60M
  • $100K - 5M
View ProfileView
4
Umoja's Competitor - TScan logo

Gavin MacBeath

CEO

85/100
100
$657.3M
$2.8M
  • $657.3M
    $2.8M
  • 100
    $657.3M
  • $2.8M
  • 85/100
  • 100
  • $657.3M
  • $2.8M
View ProfileView
5
Umoja's Competitor - Juno Therapeutics logo

CEO

- -
1,000 - 5,000
$1.5B
$100M - 500M
  • $1.5B
    $100M - 500M
  • 1,000 - 5,000
    $1.5B
  • $100M - 500M
  • - -
  • 1,000 - 5,000
  • $1.5B
  • $100M - 500M
View ProfileView
Umoja's top 18 competitors are Tmunity, PACT Pharma, Geneos Therapeutics, NexImmune, TScan, Juno Therapeutics, Aura, Perthera, bluebird bio, Jounce, RootPath, Novartis, Amgen, Kiadis Pharma, Amphivena, OncBioMune, Pfizer and AlloVir. Together they have raised over 10.5B between their estimated 186.3K employees. Umoja's revenue is the ranked 15th among it's top 10 competitors. The top 10 competitors average 8.7B. Umoja has 30 employees and is ranked 12th among it's top 10 competitors. The top 10 competitors average 9,805.

Umoja VS Tmunity

Tmunity is a top competitor of Umoja. Tmunity was founded in Philadelphia, Pennsylvania} in 2015. Tmunity competes in the Biotechnology industry. Compared to Umoja, Tmunity generates $4M more revenue.

Umoja VS PACT Pharma

PACT Pharma is Umoja's #2 competitor. PACT Pharma is headquartered in South San Francisco, California, and was founded in 2016. PACT Pharma competes in the Biotechnology field. PACT Pharma generates 800% the revenue of Umoja.

Umoja VS Geneos Therapeutics

Geneos Therapeutics has been one of Umoja's top competitors. Geneos Therapeutics is a Private company that was founded in 2016 in Plymouth Meeting, Pennsylvania. Like Umoja, Geneos Therapeutics also competes in the Biotechnology industry.

Looking for similar companies to Umoja?

Similar Companies

Biotechnology companies in Seattle

See 167 companies 
Biotechnology companies in Seattle Metropolitan Area

See 256 companies 
Pharmaceuticals & Biotechnology companies in Seattle

See 194 companies 
Pharmaceuticals & Biotechnology companies in Seattle Metropolitan Area

See 328 companies 
Biotechnology companies in Washington

See 370 companies 
Pharmaceuticals & Biotechnology companies in Washington

See 507 companies 
Biotechnology companies with revenue in $100K-5.0M range

See 4,537 companies 
Companies in Seattle with revenue in $100K-5.0M range

See 5,098 companies 
Biotechnology companies with employees in 25-100 range

See 5,165 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Umoja and Umoja's Competitors

Today 3:32 AMPharmabiz
Novartis announced the US Food and Drug Administration (FDA) has granted accelerated approval for Vanrafia (atrasentan), a potent and selective endothe...
April 3, 2025Endpoints News
The FDA on Thursday approved Amgen's rare disease drug Uplizna in an autoimmune disorder, setting the stage for the therapy to gain a foothold in the r...
April 2, 2025Benzinga
NICE recommended Pfizer's Adcetris for NHS use in advanced Hodgkin lymphoma, citing strong trial data and a new discount agreement with Takeda. read mo...
April 3, 2025Benzinga
FDA grants accelerated approval to Novartis' Vanrafia for IgA nephropathy, with Phase 3 data in 2026 expected to support traditional approval. read mor...
April 3, 2025IndiaMedToday
Stock swings and valuation woes are learnt to have stalled Swiss pharma giant Novartis's plans to sell its 70.68 per cent stake in Novartis India The S...
April 3, 2025Law 360
British pharmaceutical company GlaxoSmithKline PLC and New York-based Pfizer Inc. on Thursday agreed to end their legal fight over Pfizer's respiratory...
April 2, 2025Benzinga
read more...
April 2, 2025Pharmabiz
Pfizer Inc. announced that the European Commission (EC) has issued a decision amending the marketing authorization for Abrysvo, the company's bivalent ...
April 3, 2025Openpr
The Global Acute Renal Failure Market reached US$ 5.30 million in 2023 and is expected to reach US$ 11.02 million by 2031, growing at a CAGR of 9.0% du...
April 2, 2025Zacks
The latest decision makes Pfizer's Abrysvo the first RSV vaccine approved for use in non-pregnant adults under 50 years of age in the EU....

Frequently Asked Questions about Umoja

  1. Who are Umoja's top competitors?

    Umoja's top 3 competitors are Tmunity, PACT Pharma, Geneos Therapeutics.

  2. Who is similar to Umoja?

    Tmunity is the most similar to Umoja. PACT Pharma and Geneos Therapeutics are also similar to Umoja.

  1. Are Umoja and Tmunity competitors?

    Yes, Tmunity is one of Umoja’s top competitors.